Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell M Levy

Showing results (41-50 of 200) with videos related to

Pageof 20
Sort By:
Critical Care Medicine|July 29, 2021
Temporal Trends in ICU Survival for Coronavirus Disease 2019: A Bumpy RoadHallie C Prescott, Mitchell M Levy
Critical Care Medicine|November 13, 2020
Survival From Severe Coronavirus Disease 2019: Is It Changing?Hallie C Prescott, Mitchell M Levy
Clinics in Chest Medicine|October 29, 2008
Biomarkers: diagnosis and risk assessment in sepsisCorey E Ventetuolo, Mitchell M Levy
JAMA|January 21, 2011
Improving the science and politics of quality improvementJ Randall Curtis, Mitchell M Levy
Critical Care Medicine|January 24, 2007
Rationing and critical care medicineNicholas S Ward, Mitchell M Levy
Clinical Journal of the American Society of Nephrology : CJASN|November 9, 2007
Sepsis: a clinical updateCorey E Ventetuolo, Mitchell M Levy
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Vasoactive drug use in septic shockMichael L Stanchina, Mitchell M Levy
Intensive Care Medicine|October 3, 2013
Re-visiting visiting hoursMitchell M Levy, Daniel De Backer
Chest|May 7, 2014
Our responsibility for training physicians to understand the effect patient death has on them: the role of the intensivistJ Randall Curtis, Mitchell M Levy
Critical Care Clinics|March 29, 2011
Cardiac biomarkers in the critically illCorey E Ventetuolo, Mitchell M Levy
Pageof 20

Showing results (41-50 of 200) with videos related to

Sort By:
Pageof 20
Critical Care Medicine|July 29, 2021
Temporal Trends in ICU Survival for Coronavirus Disease 2019: A Bumpy RoadHallie C Prescott, Mitchell M Levy
Critical Care Medicine|November 13, 2020
Survival From Severe Coronavirus Disease 2019: Is It Changing?Hallie C Prescott, Mitchell M Levy
Clinics in Chest Medicine|October 29, 2008
Biomarkers: diagnosis and risk assessment in sepsisCorey E Ventetuolo, Mitchell M Levy
JAMA|January 21, 2011
Improving the science and politics of quality improvementJ Randall Curtis, Mitchell M Levy
Critical Care Medicine|January 24, 2007
Rationing and critical care medicineNicholas S Ward, Mitchell M Levy
Clinical Journal of the American Society of Nephrology : CJASN|November 9, 2007
Sepsis: a clinical updateCorey E Ventetuolo, Mitchell M Levy
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Vasoactive drug use in septic shockMichael L Stanchina, Mitchell M Levy
Intensive Care Medicine|October 3, 2013
Re-visiting visiting hoursMitchell M Levy, Daniel De Backer
Chest|May 7, 2014
Our responsibility for training physicians to understand the effect patient death has on them: the role of the intensivistJ Randall Curtis, Mitchell M Levy
Critical Care Clinics|March 29, 2011
Cardiac biomarkers in the critically illCorey E Ventetuolo, Mitchell M Levy
Pageof 20